AstraZeneca PLC is 139.3x more valuable than Pharvaris N.V. by market capitalization ($286.27 B vs $2.05 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PHVS | AZN |
|---|---|---|
| Market cap | $2.05 B | $286.27 B |
| US-listed rank | #2084 | #45 |
| SEC filings | 254 | 1,004 |
AstraZeneca PLC is 139.3x more valuable than Pharvaris N.V. by market capitalization ($286.27 B vs $2.05 B).
Full pages: Pharvaris N.V. and AstraZeneca PLC, or browse the full rankings.